These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1835251)

  • 1. Paroxetine and imipramine treatment of depressive patients in a controlled multicentre study with plasma amino acid measurements.
    Nielsen OA; Morsing I; Petersen JS; Larsen T; Møller SE; Manniche PM; Skausig OB
    Acta Psychiatr Scand; 1991 Sep; 84(3):233-41. PubMed ID: 1835251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paroxetine in the treatment of depression: a comparison with imipramine and placebo.
    Feighner JP; Boyer WF
    Acta Psychiatr Scand Suppl; 1989; 350():125-9. PubMed ID: 2530763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pharmacokinetic dose titration study in adult and elderly depressed patients.
    Hebenstreit GF; Fellerer K; Zöchling R; Zentz A; Dunbar GC
    Acta Psychiatr Scand Suppl; 1989; 350():81-4. PubMed ID: 2530795
    [No Abstract]   [Full Text] [Related]  

  • 4. Paroxetine plasma levels: lack of correlation with efficacy or adverse events.
    Tasker TC; Kaye CM; Zussman BD; Link CG
    Acta Psychiatr Scand Suppl; 1989; 350():152-5. PubMed ID: 2530776
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparison of paroxetine, imipramine and placebo in depressed out-patients.
    Dunbar GC; Cohn JB; Fabre LF; Feighner JP; Fieve RR; Mendels J; Shrivastava RK
    Br J Psychiatry; 1991 Sep; 159():394-8. PubMed ID: 1835664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacokinetics of paroxetine in elderly depressed patients.
    Ghose K
    Acta Psychiatr Scand Suppl; 1989; 350():87-8. PubMed ID: 2530797
    [No Abstract]   [Full Text] [Related]  

  • 7. Paroxetine in the treatment of depression: a comparison with imipramine and placebo.
    Feighner JP; Boyer WF
    J Clin Psychiatry; 1992 Feb; 53 Suppl():44-7. PubMed ID: 1531824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A placebo- and imipramine-controlled study of paroxetine.
    Cohn JB; Crowder JE; Wilcox CS; Ryan PJ
    Psychopharmacol Bull; 1990; 26(2):185-9. PubMed ID: 2146697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between parameters of serotonin transport and antidepressant plasma levels or therapeutic response in depressive patients treated with paroxetine and amitriptyline.
    Kuhs H; Schlake HP; Rolf LH; Rudolf GA
    Acta Psychiatr Scand; 1992 May; 85(5):364-9. PubMed ID: 1534961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 6-week, double-blind trial of paroxetine, imipramine, and placebo in depressed outpatients.
    Fabre LF
    J Clin Psychiatry; 1992 Feb; 53 Suppl():40-3. PubMed ID: 1531823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paroxetine and imipramine in the treatment of depressive patients in psychiatric practice.
    Ohrberg S; Christiansen PE; Severin B; Calberg H; Nilakantan B; Borup A; Søgaard J; Larsen SB; Loldrup D; Bahr B
    Acta Psychiatr Scand; 1992 Dec; 86(6):437-44. PubMed ID: 1471536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind comparison of paroxetine, imipramine, and placebo in major depression.
    Shrivastava RK; Shrivastava SH; Overweg N; Blumhardt CL
    J Clin Psychiatry; 1992 Feb; 53 Suppl():48-51. PubMed ID: 1531825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 12-week double-blind multi-centre study of paroxetine and imipramine in hospitalized depressed patients.
    Arminen SL; Ikonen U; Pulkkinen P; Leinonen E; Mahlanen A; Koponen H; Kourula K; Ryyppö J; Korpela V; Lehtonen ML
    Acta Psychiatr Scand; 1994 Jun; 89(6):382-9. PubMed ID: 8085467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relapse prevention by means of paroxetine in ECT-treated patients with major depression: a comparison with imipramine and placebo in medium-term continuation therapy.
    Lauritzen L; Odgaard K; Clemmesen L; Lunde M; Ohrström J; Black C; Bech P
    Acta Psychiatr Scand; 1996 Oct; 94(4):241-51. PubMed ID: 8911559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study. Danish University Antidepressant Group.
    J Affect Disord; 1990 Apr; 18(4):289-99. PubMed ID: 2140382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind comparison of paroxetine, imipramine and placebo in depressed outpatients.
    Feighner JP
    Int Clin Psychopharmacol; 1992 Jun; 6 Suppl 4():31-5. PubMed ID: 1431008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind, multicentre study of paroxetine versus clomipramine in depressed elderly patients.
    Guillibert E; Pelicier Y; Archambault JC; Chabannes JP; Clerc G; Desvilles M; Guibert M; Pagot R; Poisat JL; Thobie Y
    Acta Psychiatr Scand Suppl; 1989; 350():132-4. PubMed ID: 2530766
    [No Abstract]   [Full Text] [Related]  

  • 18. Paroxetine in major depression: a double-blind trial with imipramine and placebo.
    Cohn JB; Wilcox CS
    J Clin Psychiatry; 1992 Feb; 53 Suppl():52-6. PubMed ID: 1531826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind, multicentre study of paroxetine and mianserin in depression.
    Mertens C; Pintens H
    Acta Psychiatr Scand Suppl; 1989; 350():140. PubMed ID: 2530770
    [No Abstract]   [Full Text] [Related]  

  • 20. A double-blind study of the comparative antidepressant effect of paroxetine and amitriptyline.
    Kuhs H; Rudolf GA
    Acta Psychiatr Scand Suppl; 1989; 350():145-6. PubMed ID: 2530773
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.